Core Viewpoint - Lin Qingxuan officially listed on the Hong Kong Stock Exchange on December 30, becoming the first high-end domestic skincare stock in the Hong Kong market, showcasing the strength and confidence of domestic brands on the international stage [1] Group 1: Company Overview - Lin Qingxuan focuses on anti-wrinkle and firming skincare products, providing high-end solutions with natural camellia ingredients [1] - The company has established a strong professional recognition in the "oil-based skincare" sector, ranking first among domestic high-end skincare brands and being the only domestic representative among the top 15 high-end skincare brands in China [3] - The brand has achieved over 50 million sales of its camellia oil facial essence, maintaining the top position in the market for 11 consecutive years [3] Group 2: Product Development - The fifth generation of the camellia anti-wrinkle essence oil has been launched, featuring comprehensive iterations in efficacy verification, core ingredient ratios, and packaging [5] - The company has expanded its product matrix with several recognized products, including black gold cream 2.0 and high SPF sunscreen [6] - Lin Qingxuan controls the entire value chain from seedling cultivation to sales, ensuring product quality and stable supply [6] Group 3: Research and Innovation - The company has over 600 formula achievements and 87 patents, with 46 being invention patents, focusing on key areas like camellia extraction and anti-wrinkle technology [7] - A joint research laboratory with Shanghai Jiao Tong University will be established to explore anti-wrinkle mechanisms at the cellular level, aiming to integrate natural plant activity with modern life sciences [7] Group 4: Financial Performance - From 2022 to 2024, the company's revenue grew from 690 million to 1.21 billion, with a compound annual growth rate of 32.3%, significantly above the industry average [9] - In the first half of 2025, revenue surged by 98.3% to 1.05 billion compared to the same period in 2024, with adjusted net profit increasing by 117.4% [9] - The company aims to leverage its listing as a new starting point to further develop core technologies and expand its product matrix [9]

年末的港股IPO市场热闹非凡，锣声回荡。12月30日，6家企业同日登陆港交所，包括英硅智能（03696.HK）、五一视界（06651.HK）、林清轩 （02657.HK）、迅策（03317.HK）及天数智芯（09903.HK）等。 林清轩本次共发行1396.645万股，其中香港发售139.665万股，每股发售价77.77港元，募集资金净额约9.97亿港元。公司获得投资者踊跃认购，香港公开发售 获认购1235.81倍，高于去年另一国货护肤品牌毛戈平（01318.HK）不到1000倍的认购倍数。 | 香港公開發售 | | | --- | --- | | 有效申請數目 | 169.712 | | 受理申請數目 | 24.037 | | 認購額 | 1.235.81 倍 | | 香 港 公 開 發 售 項 下 初 步 可 供 認 購 發 售 股 份 數 目 | 1,396,650 | | 由國際發售重新分配的發售股份數目(回補後 | 不 | | 香港公開發售項下最終發售股份數目 | 1.396.650 | | 香 港 公 開 發 售 項 下 發 售 股 份 佔 全 球 發 售 項 下 發 售 股 份 的 百 分 比 ...

根据灼识咨询的资料，于2024年，按零售额计，林清轩在中国所有高端国货护肤品牌中排名第一，占据 1.4%的市场份额。是唯一跻身中国前15大高端护肤品牌(包括国货及国际品牌)的国货品牌，整体排名第 13位。 本文源自：智通财经网 智通财经获悉，林清轩(02657)首挂上市，公告显示，每股定价77.77港元，共发行1396.65万股股份，每 手50股，所得款项净额约9.971亿港元。截至发稿，涨9.3%，报85港元，成交额2.04亿港元。 公开资料显示，林清轩为中国高端国货护肤品牌，聚焦抗皱紧致类护肤品市场，并以长期致力于旗舰品 牌林清轩提供基于天然、山茶花成分的高端护肤改善方案而著称。自2012年展开山茶花护肤品研究以 来，公司开创"以油养肤"理念，首创山茶花面部精华油。公司首款山茶花精华油于2014年问世，该款产 品为公司的核心以油养肤产品线奠定基础。截至2025年6月30日，山茶花精华油自推出以来已累计销售 逾4500万瓶，根据灼识咨询的资料，按全渠道销售的总零售额计自2014年以来连续11年于所有面部精华 油产品中稳居全国榜首。该产品亦为中国面部精华油品类中连续8年零售额超过人民币1亿元的唯一一款 产品。 ...

林清轩(02657)首挂上市，公告显示，每股定价77.77港元，共发行1396.65万股股份，每手50股，所得款 项净额约9.971亿港元。截至发稿，涨9.3%，报85港元，成交额2.04亿港元。 公开资料显示，林清轩为中国高端国货护肤品牌，聚焦抗皱紧致类护肤品市场，并以长期致力于旗舰品 牌林清轩提供基于天然、山茶花成分的高端护肤改善方案而著称。自2012年展开山茶花护肤品研究以 来，公司开创"以油养肤"理念，首创山茶花面部精华油。公司首款山茶花精华油于2014年问世，该款产 品为公司的核心以油养肤产品线奠定基础。截至2025年6月30日，山茶花精华油自推出以来已累计销售 逾4500万瓶，根据灼识咨询的资料，按全渠道销售的总零售额计自2014年以来连续11年于所有面部精华 油产品中稳居全国榜首。该产品亦为中国面部精华油品类中连续8年零售额超过人民币1亿元的唯一一款 产品。 根据灼识咨询的资料，于2024年，按零售额计，林清轩在中国所有高端国货护肤品牌中排名第一，占据 1.4%的市场份额。是唯一跻身中国前15大高端护肤品牌(包括国货及国际品牌)的国货品牌，整体排名第 13位。 ...

根据灼识咨询的资料，于2024年，按零售额计，林清轩在中国所有高端国货护肤品牌中排名第一，占据 1.4%的市场份额。是唯一跻身中国前15大高端护肤品牌(包括国货及国际品牌)的国货品牌，整体排名第 13位。 智通财经APP获悉，林清轩(02657)首挂上市，公告显示，每股定价77.77港元，共发行1396.65万股股 份，每手50股，所得款项净额约9.971亿港元。截至发稿，涨9.3%，报85港元，成交额2.04亿港元。 公开资料显示，林清轩为中国高端国货护肤品牌，聚焦抗皱紧致类护肤品市场，并以长期致力于旗舰品 牌林清轩提供基于天然、山茶花成分的高端护肤改善方案而著称。自2012年展开山茶花护肤品研究以 来，公司开创"以油养肤"理念，首创山茶花面部精华油。公司首款山茶花精华油于2014年问世，该款产 品为公司的核心以油养肤产品线奠定基础。截至2025年6月30日，山茶花精华油自推出以来已累计销售 逾4500万瓶，根据灼识咨询的资料，按全渠道销售的总零售额计自2014年以来连续11年于所有面部精华 油产品中稳居全国榜首。该产品亦为中国面部精华油品类中连续8年零售额超过人民币1亿元的唯一一款 产品。 ...

Investment Rating - Industry rating: "Accumulate" (maintained) [7] Core Insights - The approval of the cross-linked recombinant collagen implant by Chuangjian Medical on December 23, 2025, marks a significant addition to the recombinant collagen industry, which is expected to expand further [7] - Lin Qingxuan has passed the Hong Kong Stock Exchange listing hearing, potentially becoming the first high-end domestic skincare stock in Hong Kong [7] - The "oil-based skincare" brand Afu released the industry's first technical standard for functional skincare products on December 8, 2025, supporting the standardized development of the "oil-based skincare" sector [7] Summary by Sections Industry Performance - Over the past 12 months, the industry has shown a relative return of -21.5% compared to the CSI 300 index, with absolute returns of -4.52% [3] Key Events - Chuangjian Medical's recombinant collagen implant is composed of cross-linked recombinant collagen hydrogel and is approved for facial dermal filling to correct moderate to severe dynamic wrinkles [7] - Lin Qingxuan's core product, camellia oil essence, has seen its revenue share increase from 31.5% in 2022 to an expected 45.5% in the first half of 2025, maintaining its position as the top-selling facial essence oil in China for 11 consecutive years [7] Investment Recommendations - The successful approval of Chuangjian Medical's product is expected to enhance industry growth, with a recommendation to monitor the product's market performance post-launch [7] - The sales of essence oils across major online platforms are projected to exceed 9.5 billion yuan from March 2024 to February 2025, with facial essence oils experiencing a 36% growth, indicating a strong market demand [7]

www.hczq.com 证券研究报告 化妆品行业跟踪：林清轩通过港交所聆讯 2025年12月29日 分析师 汤秀洁 执业编号：S0360525080008 邮箱：tangxiujie@hcyjs.com 联系人 王笑飞 执业编号：S0360125090005 邮箱：wangxiaofei@hcyjs.com 本报告由华创证券有限责任公司编制 。本公司不会因接收人收到本报告而视其为客户。华创证券对这些信息的准确性和完整性不作任何保证。报告中的内容和意见仅供参考， 并不构成本公司对所述证券买卖的出价或询价。本报告所载信息均为个人观点，并不构成对所涉及证券的个人投资建议。 请仔细阅读PPT后部分的分析师声明及免责声明。 @2021 华创 版权所有 摘要 证券研究报告 此页包含机密资料，其全部或任何部分不可被复制或再发送。本页不构成对任何产品的要约出售/购买、招揽或建议。关于免责声明全文，详见本PPT最后部分。 2 林清轩：甄选高山红山茶花，开创以油养肤理念，连续11年位居精华油榜首，线下554家门店并逐步发力电商，精耕细作铸就国货高端品牌。 行业：预测2025年以油养肤市场规模从2024年77亿元同比增长45%至 ...

Investment Rating - The industry investment rating is "Positive" (maintained) [1] Core Insights - The report highlights the rapid growth of the community dining sector in China, with the market size expected to reach RMB 2,137.6 billion by 2028, reflecting a compound annual growth rate (CAGR) of 9.4% from 2023 to 2028 [4][16] - The Hainan Free Trade Port has seen significant policy benefits, leading to increased consumer and trade activity, with notable growth in duty-free shopping and foreign trade enterprises [12][13] - The "oil-based skincare" segment is experiencing expansion, with both international and domestic brands enhancing their product offerings, which is expected to drive industry growth [27][28] Summary by Sections Hainan Free Trade Port Tracking - The first week of the Hainan Free Trade Port's full closure saw duty-free shopping amounting to RMB 1.1 billion, with a year-on-year increase of 54.9% [12] - The number of new foreign trade registered enterprises in Hainan increased by 2.3 times year-on-year, with over 30,000 new registered customs declaration units for the year, up over 40% [12] - Passenger throughput at Meilan Airport increased by 11.8% year-on-year during the first week of closure [13] Community Dining - The community dining sector has grown rapidly, with the market size increasing from RMB 1,141.4 billion in 2018 to RMB 1,365.8 billion in 2023, a CAGR of 3.7% [14][19] - JD's "Seven Fresh Kitchen" has opened over 30 stores in Beijing, aiming to establish 10,000 stores in three years, focusing on a dual model of delivery and self-pickup [18][24] - The "锅圈" (Guoquan) has expanded its store size and product offerings, transitioning from a simple grocery model to a comprehensive community kitchen service [24] Oil-based Skincare - The "oil-based skincare" market is seeing increased competition from both international luxury brands and domestic brands, with a focus on high-quality ingredients and effective formulations [27][28] - Lin Qingxuan has maintained the top market share on platforms like Taobao and Douyin, with a significant increase in its market share on Douyin by 13.8 percentage points compared to the previous year [28][33] - The report emphasizes the importance of product innovation and the introduction of new active ingredients to meet diverse consumer needs [28] Market Performance Overview - The Hong Kong retail sector outperformed the Hang Seng Index, while consumer services and media sectors lagged behind [34][35] - The report notes that the duty-free and dining sectors have shown strong performance, with specific companies like 多想云 (Duoxiangyun) and 中国中免 (China Duty Free Group) leading in stock performance [43][44]

Investment Rating - The report indicates a cautious outlook for the cosmetics and medical beauty sector, with the beauty care index declining by 1.1% from December 19 to December 26, 2025, underperforming the market [3][4]. Core Insights - Lin Qingxuan is set to lead the high-end domestic essence oil market with its upcoming IPO on December 30, 2025, aiming to issue 13.9665 million H shares. The brand has established itself as a benchmark in high-end domestic skincare, with a market share of 1.4% in 2024, ranking 13th among high-end skincare brands [3][8]. - The company has shown impressive growth, with revenue increasing from 690 million yuan in 2022 to 1.21 billion yuan in 2024, representing a compound annual growth rate (CAGR) of 32.7%. The net profit margin for the first half of 2025 reached 17.3%, with net profit doubling to 182 million yuan year-on-year [3][8]. Summary by Sections Industry Performance - The cosmetics and medical beauty sector has underperformed the market, with the cosmetics index down 1.3%, lagging behind the Shenwan A index by 4.2 percentage points [3][4]. - The top-performing stocks in the sector included Yanjiang Co. (+10.9%), Mingchen Health (+9.2%), and Hongmian Co. (+8.6%), while the worst performers were Nobon Co. (-4.0%), Mengyue Care (-3.4%), and Shangmei Co. (-3.1%) [4]. Key Company Updates - Yiwang Yichuang (300792SZ) is highlighted for its robust operational foundation in e-commerce agency services, leveraging AI to enhance performance. The company has seen a turnaround in net profit growth, with a 4% year-on-year increase in the first three quarters of 2025 [9][10]. - The approval of Jiangsu Chuangjian Medical's "cross-linked recombinant collagen implant" on December 24, 2025, marks a significant advancement in the medical beauty sector, targeting facial dermal filling [19][21]. Market Trends - The retail sales of cosmetics in China for the first eleven months of 2025 reached 428.5 billion yuan, with a year-on-year growth of 4.8%. The sales in November alone grew by 6.1%, driven by promotional events [16][20]. - The report notes a shift in market dynamics, with domestic brands gaining market share against international competitors. In 2024, the domestic skincare market is projected to reach 271.2 billion yuan, despite a decline of 3.7% year-on-year [24][26].

Investment Rating - The investment rating for the industry is "Outperform the Market" [2][3] Core Insights - The beauty industry has entered a stable growth phase, with increasing consumer demand differentiation and intensified competition, necessitating higher operational standards for brand management [4][65] - Domestic brands, including Lin Qingxuan, have made significant progress in the high-end market, leveraging unique Chinese ingredients to create differentiated products and enhancing brand value through effective channel strategies [4][65] - Lin Qingxuan is positioned as a leading domestic high-end skincare brand, ranking 13th among all high-end skincare brands in China with a market share of 1.4% [5][26] Company Overview - Lin Qingxuan plans to officially list on the Hong Kong Stock Exchange on December 30, issuing approximately 13.97 million H shares at an offering price of HKD 77.77 per share, aiming to raise around HKD 1.086 billion [4] - The company has established a full industry chain from raw material planting to R&D, production, and sales, focusing on its core product, the Camellia Oil, which has been a market leader for 11 consecutive years [5][6] Financial Performance - In 2024, Lin Qingxuan is projected to achieve revenue of CNY 1.21 billion, a year-on-year increase of 50.27%, and a net profit of CNY 187 million, up 121.06% [15] - The company has maintained rapid revenue growth over the past three years, with a significant increase in profit margins, indicating strong operational efficiency [15][20] Product and Channel Strategy - The core product, Camellia Oil, has seen substantial revenue growth, contributing 46% of total revenue in the first half of 2025, with a remarkable growth rate of 176% [39] - The company has a balanced online and offline channel strategy, with online sales accounting for 65% of total revenue in the first half of 2025, reflecting a 137% growth [18][47] Brand Positioning and Customer Base - Lin Qingxuan has over 5.6 million active customers, with an average annual repurchase rate of 33.5%, indicating strong brand loyalty [30] - The brand is actively expanding its customer base, targeting younger consumers aged 18 to 24 through affordable yet effective skincare solutions [34] Future Growth Plans - The company plans to use the funds raised from the IPO to enhance brand marketing, upgrade supply chain capabilities, and explore overseas markets, aiming for sustainable growth and brand diversification [62][64]